

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 6.52030834 |
| 2 | cytidine metabolic process (GO:0046087) | 6.52030834 |
| 3 | cytidine catabolic process (GO:0006216) | 6.52030834 |
| 4 | regulation of mitochondrial translation (GO:0070129) | 6.44655169 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.81344649 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.78425205 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.59910762 |
| 8 | DNA deamination (GO:0045006) | 5.58318774 |
| 9 | vocalization behavior (GO:0071625) | 5.40047359 |
| 10 | glutamate secretion (GO:0014047) | 5.36252406 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.29748351 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.19209545 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.19167441 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 5.00321394 |
| 15 | positive regulation of cell size (GO:0045793) | 4.93610180 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.85743113 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.80944221 |
| 18 | synaptic vesicle maturation (GO:0016188) | 4.80242422 |
| 19 | eosinophil chemotaxis (GO:0048245) | 4.79129647 |
| 20 | negative regulation by host of viral transcription (GO:0043922) | 4.78764909 |
| 21 | protein localization to synapse (GO:0035418) | 4.76770672 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.74757029 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.69603759 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.67647374 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.61378431 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.60266272 |
| 27 | pyrimidine nucleoside salvage (GO:0043097) | 4.57145166 |
| 28 | pyrimidine-containing compound salvage (GO:0008655) | 4.57145166 |
| 29 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.37572872 |
| 30 | locomotory exploration behavior (GO:0035641) | 4.36080048 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.35945724 |
| 32 | eosinophil migration (GO:0072677) | 4.24841963 |
| 33 | cellular protein complex localization (GO:0034629) | 4.22051703 |
| 34 | chaperone-mediated protein transport (GO:0072321) | 4.18138049 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.17396731 |
| 36 | ncRNA 3-end processing (GO:0043628) | 4.16662732 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 4.16279154 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.16248787 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 4.06497060 |
| 40 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.99747962 |
| 41 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.95994104 |
| 42 | UMP metabolic process (GO:0046049) | 3.95994104 |
| 43 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.95994104 |
| 44 | UMP biosynthetic process (GO:0006222) | 3.95994104 |
| 45 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.95603579 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.86933432 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.86599517 |
| 48 | glutamate receptor signaling pathway (GO:0007215) | 3.85565663 |
| 49 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.84730932 |
| 50 | iron-sulfur cluster assembly (GO:0016226) | 3.82434077 |
| 51 | metallo-sulfur cluster assembly (GO:0031163) | 3.82434077 |
| 52 | postsynaptic membrane organization (GO:0001941) | 3.79888330 |
| 53 | nucleoside salvage (GO:0043174) | 3.79261349 |
| 54 | neurotransmitter transport (GO:0006836) | 3.78906551 |
| 55 | exploration behavior (GO:0035640) | 3.78791917 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.78520717 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76804834 |
| 58 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76546691 |
| 59 | proline transport (GO:0015824) | 3.73646727 |
| 60 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72810202 |
| 61 | positive regulation of synapse maturation (GO:0090129) | 3.71793950 |
| 62 | arginine catabolic process (GO:0006527) | 3.68894643 |
| 63 | presynaptic membrane organization (GO:0097090) | 3.67043447 |
| 64 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.65985243 |
| 65 | protein complex localization (GO:0031503) | 3.64387723 |
| 66 | neuron recognition (GO:0008038) | 3.64323517 |
| 67 | diaphragm development (GO:0060539) | 3.62832326 |
| 68 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.62363607 |
| 69 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.62363607 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.62144192 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.62144192 |
| 72 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.61504577 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.58677373 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 3.55992641 |
| 75 | protein maturation by protein folding (GO:0022417) | 3.53124283 |
| 76 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.52447815 |
| 77 | transferrin transport (GO:0033572) | 3.52395521 |
| 78 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.51898952 |
| 79 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.51594430 |
| 80 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.51315120 |
| 81 | regulation of neurotransmitter levels (GO:0001505) | 3.51307931 |
| 82 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.48276801 |
| 83 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.47529929 |
| 84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46805994 |
| 85 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.43807993 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.43321515 |
| 87 | protein deneddylation (GO:0000338) | 3.42279573 |
| 88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.41497478 |
| 89 | regulation of neurotransmitter secretion (GO:0046928) | 3.41056509 |
| 90 | response to histamine (GO:0034776) | 3.40389910 |
| 91 | positive regulation of membrane potential (GO:0045838) | 3.40082179 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39964658 |
| 93 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.39523651 |
| 94 | proteasome assembly (GO:0043248) | 3.39497609 |
| 95 | nucleotide salvage (GO:0043173) | 3.36288420 |
| 96 | negative regulation of viral transcription (GO:0032897) | 3.36172525 |
| 97 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.32171624 |
| 98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.30898529 |
| 99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.30898529 |
| 100 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.30898529 |
| 101 | positive regulation of viral genome replication (GO:0045070) | 3.30680902 |
| 102 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.30397535 |
| 103 | ferric iron transport (GO:0015682) | 3.29073932 |
| 104 | trivalent inorganic cation transport (GO:0072512) | 3.29073932 |
| 105 | activation of protein kinase A activity (GO:0034199) | 3.29017172 |
| 106 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28841747 |
| 107 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.28304110 |
| 108 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28079637 |
| 109 | CTP biosynthetic process (GO:0006241) | 3.27362426 |
| 110 | CTP metabolic process (GO:0046036) | 3.27362426 |
| 111 | layer formation in cerebral cortex (GO:0021819) | 3.27309249 |
| 112 | long-term memory (GO:0007616) | 3.27271759 |
| 113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.27111262 |
| 114 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.27111262 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 3.26574353 |
| 116 | respiratory chain complex IV assembly (GO:0008535) | 3.25936858 |
| 117 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.25868800 |
| 118 | neuromuscular process controlling posture (GO:0050884) | 3.24805910 |
| 119 | * long-term synaptic potentiation (GO:0060291) | 3.24444939 |
| 120 | cerebellar granule cell differentiation (GO:0021707) | 3.24121604 |
| 121 | regulation of glutamate secretion (GO:0014048) | 3.23201576 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22363406 |
| 123 | startle response (GO:0001964) | 3.21724223 |
| 124 | regulation of activation of Janus kinase activity (GO:0010533) | 3.21655554 |
| 125 | regulation of chronic inflammatory response (GO:0002676) | 3.21115428 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21065675 |
| 127 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21065675 |
| 128 | positive regulation of synapse assembly (GO:0051965) | 3.20327549 |
| 129 | regulation of neurotransmitter transport (GO:0051588) | 3.19977147 |
| 130 | * regulation of synaptic plasticity (GO:0048167) | 3.19099233 |
| 131 | behavioral response to cocaine (GO:0048148) | 3.19056964 |
| 132 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.17663347 |
| 133 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.17321184 |
| 134 | positive regulation of translational initiation (GO:0045948) | 3.16896558 |
| 135 | base-excision repair, AP site formation (GO:0006285) | 3.16285462 |
| 136 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.15883877 |
| 137 | skeletal muscle organ development (GO:0060538) | 3.15205305 |
| 138 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.14788844 |
| 139 | histone arginine methylation (GO:0034969) | 3.14618206 |
| 140 | cytochrome complex assembly (GO:0017004) | 3.14359897 |
| 141 | axonal fasciculation (GO:0007413) | 3.13358854 |
| 142 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.13073049 |
| 143 | positive regulation of T cell apoptotic process (GO:0070234) | 3.12836133 |
| 144 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.12258446 |
| 145 | regulation of vesicle fusion (GO:0031338) | 3.11152625 |
| 146 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.10031737 |
| 147 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.09972293 |
| 148 | adenine nucleotide transport (GO:0051503) | 3.09913167 |
| 149 | macrophage chemotaxis (GO:0048246) | 3.07565541 |
| 150 | transmission of nerve impulse (GO:0019226) | 3.07181214 |
| 151 | positive regulation of ligase activity (GO:0051351) | 3.06851100 |
| 152 | synaptic transmission (GO:0007268) | 3.06123795 |
| 153 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06042625 |
| 154 | establishment of synaptic vesicle localization (GO:0097480) | 3.05570875 |
| 155 | synaptic vesicle transport (GO:0048489) | 3.05570875 |
| 156 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.05325712 |
| 157 | regulation of synapse maturation (GO:0090128) | 3.05221802 |
| 158 | female mating behavior (GO:0060180) | 3.03990764 |
| 159 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.03438845 |
| 160 | regulation of female receptivity (GO:0045924) | 3.03227105 |
| 161 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.00670073 |
| 162 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.00310120 |
| 163 | behavioral defense response (GO:0002209) | 2.99807050 |
| 164 | behavioral fear response (GO:0001662) | 2.99807050 |
| 165 | synapse assembly (GO:0007416) | 2.98496900 |
| 166 | striatum development (GO:0021756) | 2.98103757 |
| 167 | regulation of cellular respiration (GO:0043457) | 2.96817110 |
| 168 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.96437745 |
| 169 | mechanosensory behavior (GO:0007638) | 2.96032161 |
| 170 | membrane depolarization (GO:0051899) | 2.95978285 |
| 171 | cullin deneddylation (GO:0010388) | 2.95909586 |
| 172 | auditory behavior (GO:0031223) | 2.95483516 |
| 173 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.94206905 |
| 174 | * regulation of synaptic transmission (GO:0050804) | 2.93303182 |
| 175 | * positive regulation of synaptic transmission (GO:0050806) | 2.92849483 |
| 176 | membrane hyperpolarization (GO:0060081) | 2.92822998 |
| 177 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.91645769 |
| 178 | arginine metabolic process (GO:0006525) | 2.91009925 |
| 179 | regulation of ligase activity (GO:0051340) | 2.90901270 |
| 180 | peptidyl-arginine N-methylation (GO:0035246) | 2.89940373 |
| 181 | peptidyl-arginine methylation (GO:0018216) | 2.89940373 |
| 182 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89828917 |
| 183 | membrane depolarization during action potential (GO:0086010) | 2.89318354 |
| 184 | learning (GO:0007612) | 2.88655757 |
| 185 | fear response (GO:0042596) | 2.85504270 |
| 186 | dendritic spine morphogenesis (GO:0060997) | 2.85440630 |
| 187 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.85388542 |
| 188 | establishment of vesicle localization (GO:0051650) | 2.84305742 |
| 189 | inactivation of MAPK activity (GO:0000188) | 2.82770936 |
| 190 | modulation by host of viral transcription (GO:0043921) | 2.80142673 |
| 191 | modulation by host of symbiont transcription (GO:0052472) | 2.80142673 |
| 192 | negative regulation of T cell apoptotic process (GO:0070233) | 2.75160982 |
| 193 | COPI coating of Golgi vesicle (GO:0048205) | 2.74095712 |
| 194 | Golgi transport vesicle coating (GO:0048200) | 2.74095712 |
| 195 | positive regulation of cell cycle arrest (GO:0071158) | 2.71015299 |
| 196 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.69289792 |
| 197 | establishment of protein localization to mitochondrion (GO:0072655) | 2.68170346 |
| 198 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68040018 |
| 199 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.66816063 |
| 200 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.64527841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.48698972 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 4.66388584 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.55522709 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.39289960 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.32490687 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.10633896 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.09018432 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.08463961 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.95139380 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.26764465 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14507508 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98678819 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.94613199 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.92794941 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.89105474 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.83158390 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.82819091 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.74935096 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.70284339 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.57533380 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57515375 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.57167388 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.56839455 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55749600 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54302856 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53620659 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52517349 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51799813 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51799813 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49695674 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.47620143 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43940057 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42242606 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.41369577 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40844253 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33839531 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30897090 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29359029 |
| 39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.28330331 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.28152678 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27797837 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.24940537 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20926035 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16194666 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11186001 |
| 46 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.10476440 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10250276 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08553776 |
| 49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04572406 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00580060 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99911305 |
| 52 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98118401 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96152719 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95711916 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91976238 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91761517 |
| 57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.91266149 |
| 58 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90658398 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90127233 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89829091 |
| 61 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.88027541 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87194616 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84245314 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79885981 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.78497621 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75132255 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73763606 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70600622 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70276847 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68596884 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67895008 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64201124 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62738500 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59226237 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57732972 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.54167959 |
| 77 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.53592698 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52218389 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.51582669 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49363109 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48521226 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.47745512 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47068461 |
| 84 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.45204635 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45045998 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43082788 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42860223 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42546808 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41363017 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40843066 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39998994 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39547104 |
| 93 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39339380 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38319918 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38135633 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37837561 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37194660 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37035185 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36389427 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36228932 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35537793 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35332208 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34617050 |
| 104 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34142260 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33172468 |
| 106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32865152 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31917561 |
| 108 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30024882 |
| 109 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.29862388 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29795401 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29373944 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26600382 |
| 113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26332314 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25927459 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24920334 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22411499 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20483207 |
| 118 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20235525 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 1.19032698 |
| 120 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18734850 |
| 121 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18399146 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17299752 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16935893 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15923044 |
| 125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15710044 |
| 126 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15430608 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15320456 |
| 128 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13317121 |
| 129 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13233326 |
| 130 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12661790 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12363167 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11700007 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10739743 |
| 134 | AR_19668381_ChIP-Seq_PC3_Human | 1.10456968 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10121050 |
| 136 | JUN_21703547_ChIP-Seq_K562_Human | 1.09567987 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09013601 |
| 138 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08941231 |
| 139 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07399512 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07013860 |
| 141 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06919447 |
| 142 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06468479 |
| 143 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06436377 |
| 144 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05907725 |
| 145 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05647542 |
| 146 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04317554 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04216130 |
| 148 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04037534 |
| 149 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03873400 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02637175 |
| 151 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02457379 |
| 152 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01800978 |
| 153 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00498654 |
| 154 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.00347443 |
| 155 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99915542 |
| 156 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98869567 |
| 157 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98594452 |
| 158 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98589518 |
| 159 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98312731 |
| 160 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98009708 |
| 161 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97962435 |
| 162 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97532491 |
| 163 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95233703 |
| 164 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94241923 |
| 165 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94056959 |
| 166 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93859409 |
| 167 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93437922 |
| 168 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92177126 |
| 169 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92075535 |
| 170 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91896323 |
| 171 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91474038 |
| 172 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91376509 |
| 173 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91217828 |
| 174 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89894408 |
| 175 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89379018 |
| 176 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89119479 |
| 177 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87763200 |
| 178 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87613375 |
| 179 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86936471 |
| 180 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86812765 |
| 181 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86604110 |
| 182 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86255897 |
| 183 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86255897 |
| 184 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86189831 |
| 185 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86184329 |
| 186 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.85941832 |
| 187 | MAF_26560356_Chip-Seq_TH2_Human | 0.85553870 |
| 188 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85374795 |
| 189 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85359863 |
| 190 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83533639 |
| 191 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82968439 |
| 192 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82643274 |
| 193 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82634237 |
| 194 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82536625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.32487617 |
| 2 | MP0003880_abnormal_central_pattern | 5.01263898 |
| 3 | MP0002234_abnormal_pharynx_morphology | 4.84465431 |
| 4 | MP0000566_synostosis | 4.15994494 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.89407314 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.36364948 |
| 7 | MP0009745_abnormal_behavioral_response | 3.33852120 |
| 8 | MP0009046_muscle_twitch | 3.25591055 |
| 9 | MP0004270_analgesia | 3.24755764 |
| 10 | MP0002064_seizures | 3.21240915 |
| 11 | MP0002063_abnormal_learning/memory/cond | 3.20280900 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.19467521 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.83926459 |
| 14 | MP0002736_abnormal_nociception_after | 2.80166943 |
| 15 | MP0010307_abnormal_tumor_latency | 2.68468223 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.61718991 |
| 17 | MP0002272_abnormal_nervous_system | 2.60285791 |
| 18 | MP0003786_premature_aging | 2.52851219 |
| 19 | MP0002822_catalepsy | 2.50186287 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.43162100 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.41171906 |
| 22 | MP0008058_abnormal_DNA_repair | 2.38115844 |
| 23 | MP0003122_maternal_imprinting | 2.37400293 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.34239216 |
| 25 | MP0001486_abnormal_startle_reflex | 2.31926968 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.30992939 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.20786343 |
| 28 | MP0003787_abnormal_imprinting | 2.06947125 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.06089119 |
| 30 | MP0002067_abnormal_sensory_capabilities | 2.05932004 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.05232671 |
| 32 | MP0005646_abnormal_pituitary_gland | 2.03136403 |
| 33 | MP0001970_abnormal_pain_threshold | 1.96210129 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.91779737 |
| 35 | MP0003718_maternal_effect | 1.86235092 |
| 36 | MP0001529_abnormal_vocalization | 1.86223075 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.83073496 |
| 38 | MP0001984_abnormal_olfaction | 1.81284633 |
| 39 | MP0002184_abnormal_innervation | 1.79489290 |
| 40 | MP0004924_abnormal_behavior | 1.76461352 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.76461352 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.75242892 |
| 43 | MP0006082_CNS_inflammation | 1.73701095 |
| 44 | MP0000778_abnormal_nervous_system | 1.69692629 |
| 45 | MP0003045_fibrosis | 1.69245549 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.64507401 |
| 47 | MP0002163_abnormal_gland_morphology | 1.64228938 |
| 48 | MP0003329_amyloid_beta_deposits | 1.63046149 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.62319789 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.60975720 |
| 51 | MP0004142_abnormal_muscle_tone | 1.60855280 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.60636458 |
| 53 | MP0003879_abnormal_hair_cell | 1.60459521 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.59921206 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.55667072 |
| 56 | MP0008569_lethality_at_weaning | 1.54349114 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.50631719 |
| 58 | MP0001905_abnormal_dopamine_level | 1.50618356 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.46471407 |
| 60 | MP0001346_abnormal_lacrimal_gland | 1.45624268 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.45322469 |
| 62 | MP0005671_abnormal_response_to | 1.44436156 |
| 63 | MP0000955_abnormal_spinal_cord | 1.43012331 |
| 64 | MP0010094_abnormal_chromosome_stability | 1.42471872 |
| 65 | MP0003077_abnormal_cell_cycle | 1.39947503 |
| 66 | MP0009053_abnormal_anal_canal | 1.39534855 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 1.39210718 |
| 68 | MP0001919_abnormal_reproductive_system | 1.35983552 |
| 69 | MP0004858_abnormal_nervous_system | 1.35943265 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.35056792 |
| 71 | MP0002233_abnormal_nose_morphology | 1.34841392 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.33571916 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.32025509 |
| 74 | MP0000733_abnormal_muscle_development | 1.30522049 |
| 75 | MP0001661_extended_life_span | 1.30173070 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.29141571 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.26760839 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.25172119 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.24766995 |
| 80 | MP0000751_myopathy | 1.21361312 |
| 81 | MP0001188_hyperpigmentation | 1.21311334 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.20050887 |
| 83 | MP0000537_abnormal_urethra_morphology | 1.19784617 |
| 84 | MP0004084_abnormal_cardiac_muscle | 1.17426489 |
| 85 | MP0001764_abnormal_homeostasis | 1.13679216 |
| 86 | MP0000467_abnormal_esophagus_morphology | 1.11921093 |
| 87 | MP0003633_abnormal_nervous_system | 1.10979165 |
| 88 | MP0005389_reproductive_system_phenotype | 1.10847556 |
| 89 | MP0010030_abnormal_orbit_morphology | 1.04891636 |
| 90 | MP0008260_abnormal_autophagy | 1.04275322 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 1.04204768 |
| 92 | MP0000358_abnormal_cell_content/ | 1.04150823 |
| 93 | MP0008872_abnormal_physiological_respon | 1.03439439 |
| 94 | MP0002152_abnormal_brain_morphology | 1.02166511 |
| 95 | MP0003121_genomic_imprinting | 0.99961376 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.99557228 |
| 97 | MP0004885_abnormal_endolymph | 0.98974046 |
| 98 | MP0003631_nervous_system_phenotype | 0.98598647 |
| 99 | MP0005367_renal/urinary_system_phenotyp | 0.97269959 |
| 100 | MP0000516_abnormal_urinary_system | 0.97269959 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.97180644 |
| 102 | MP0008995_early_reproductive_senescence | 0.94420931 |
| 103 | MP0002229_neurodegeneration | 0.92666783 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.91226246 |
| 105 | MP0005499_abnormal_olfactory_system | 0.91226246 |
| 106 | MP0002210_abnormal_sex_determination | 0.90650593 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.90073542 |
| 108 | MP0002160_abnormal_reproductive_system | 0.88134718 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.87307600 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.86457320 |
| 111 | MP0004085_abnormal_heartbeat | 0.85566222 |
| 112 | MP0005535_abnormal_body_temperature | 0.85493406 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.85151496 |
| 114 | MP0000749_muscle_degeneration | 0.85031350 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.84729343 |
| 116 | MP0003123_paternal_imprinting | 0.77682566 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.77643306 |
| 118 | MP0000750_abnormal_muscle_regeneration | 0.76813453 |
| 119 | MP0004233_abnormal_muscle_weight | 0.76671301 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.76520896 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.75917720 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.75711255 |
| 123 | MP0001177_atelectasis | 0.75621460 |
| 124 | MP0004742_abnormal_vestibular_system | 0.75613353 |
| 125 | MP0008874_decreased_physiological_sensi | 0.75191543 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.75151691 |
| 127 | MP0001664_abnormal_digestion | 0.74567288 |
| 128 | MP0004043_abnormal_pH_regulation | 0.71795575 |
| 129 | MP0001929_abnormal_gametogenesis | 0.70719289 |
| 130 | MP0005330_cardiomyopathy | 0.70625653 |
| 131 | MP0005332_abnormal_amino_acid | 0.70064984 |
| 132 | MP0003119_abnormal_digestive_system | 0.69171287 |
| 133 | MP0003634_abnormal_glial_cell | 0.68853045 |
| 134 | MP0003632_abnormal_nervous_system | 0.68584022 |
| 135 | MP0002102_abnormal_ear_morphology | 0.68273900 |
| 136 | MP0000604_amyloidosis | 0.67337239 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.66928231 |
| 138 | MP0001119_abnormal_female_reproductive | 0.66588507 |
| 139 | MP0000653_abnormal_sex_gland | 0.65661351 |
| 140 | MP0002638_abnormal_pupillary_reflex | 0.65412498 |
| 141 | MP0002653_abnormal_ependyma_morphology | 0.64456708 |
| 142 | MP0002249_abnormal_larynx_morphology | 0.64053233 |
| 143 | MP0003646_muscle_fatigue | 0.63661069 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.62712333 |
| 145 | MP0002090_abnormal_vision | 0.62194547 |
| 146 | MP0003283_abnormal_digestive_organ | 0.62133791 |
| 147 | MP0001145_abnormal_male_reproductive | 0.61909952 |
| 148 | MP0004133_heterotaxia | 0.61451053 |
| 149 | MP0000372_irregular_coat_pigmentation | 0.60864785 |
| 150 | MP0004484_altered_response_of | 0.60853323 |
| 151 | MP0001943_abnormal_respiration | 0.59343392 |
| 152 | MP0000026_abnormal_inner_ear | 0.54050039 |
| 153 | MP0010770_preweaning_lethality | 0.52768286 |
| 154 | MP0002082_postnatal_lethality | 0.52768286 |
| 155 | MP0003137_abnormal_impulse_conducting | 0.52441156 |
| 156 | MP0002751_abnormal_autonomic_nervous | 0.51555415 |
| 157 | MP0010769_abnormal_survival | 0.50774305 |
| 158 | MP0003956_abnormal_body_size | 0.50551723 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.47874118 |
| 160 | MP0004036_abnormal_muscle_relaxation | 0.47851435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.65148591 |
| 2 | Myokymia (HP:0002411) | 5.72408591 |
| 3 | Atonic seizures (HP:0010819) | 5.59212643 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.26963406 |
| 5 | Focal seizures (HP:0007359) | 5.25625434 |
| 6 | Febrile seizures (HP:0002373) | 4.73484878 |
| 7 | Ureteral stenosis (HP:0000071) | 4.56801823 |
| 8 | Visual hallucinations (HP:0002367) | 4.54106402 |
| 9 | Absence seizures (HP:0002121) | 4.40088985 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.37180584 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.37180584 |
| 12 | Hyperventilation (HP:0002883) | 4.30511889 |
| 13 | Sparse lateral eyebrow (HP:0005338) | 4.29745572 |
| 14 | Intestinal fistula (HP:0100819) | 4.13447512 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.11306598 |
| 16 | Ureteral obstruction (HP:0006000) | 4.08596996 |
| 17 | Dialeptic seizures (HP:0011146) | 3.97617494 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.93839209 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.78636936 |
| 20 | Short 5th finger (HP:0009237) | 3.72545429 |
| 21 | Lip pit (HP:0100267) | 3.60967295 |
| 22 | Anal stenosis (HP:0002025) | 3.56955256 |
| 23 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 3.53550780 |
| 24 | Pheochromocytoma (HP:0002666) | 3.44531208 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.29923800 |
| 26 | Polyphagia (HP:0002591) | 3.23931405 |
| 27 | Broad-based gait (HP:0002136) | 3.18046290 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 3.11424985 |
| 29 | Hepatic necrosis (HP:0002605) | 3.11158945 |
| 30 | Aplastic anemia (HP:0001915) | 3.09287935 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.08640768 |
| 32 | Hepatocellular necrosis (HP:0001404) | 3.07675329 |
| 33 | Abnormal hair whorl (HP:0010721) | 3.05135956 |
| 34 | Failure to thrive in infancy (HP:0001531) | 3.02177878 |
| 35 | Poor eye contact (HP:0000817) | 2.93555522 |
| 36 | Limb dystonia (HP:0002451) | 2.90285428 |
| 37 | T lymphocytopenia (HP:0005403) | 2.88334505 |
| 38 | Amblyopia (HP:0000646) | 2.86313324 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.84895998 |
| 40 | Gait imbalance (HP:0002141) | 2.81576309 |
| 41 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80285155 |
| 42 | Carpal bone hypoplasia (HP:0001498) | 2.79166920 |
| 43 | Ankle clonus (HP:0011448) | 2.78527005 |
| 44 | Anxiety (HP:0000739) | 2.78452300 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.77626841 |
| 46 | Cutaneous melanoma (HP:0012056) | 2.76447436 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 2.76265455 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75788845 |
| 49 | Poor suck (HP:0002033) | 2.74387093 |
| 50 | Depression (HP:0000716) | 2.73608045 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.71559454 |
| 52 | Impaired social interactions (HP:0000735) | 2.71517476 |
| 53 | Abnormal social behavior (HP:0012433) | 2.71517476 |
| 54 | Depressed nasal tip (HP:0000437) | 2.68223510 |
| 55 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.66739323 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.66639573 |
| 57 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.64789030 |
| 58 | Truncal ataxia (HP:0002078) | 2.61182279 |
| 59 | Progressive inability to walk (HP:0002505) | 2.60734610 |
| 60 | Action tremor (HP:0002345) | 2.60209399 |
| 61 | Excessive salivation (HP:0003781) | 2.59206574 |
| 62 | Drooling (HP:0002307) | 2.59206574 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.58692656 |
| 64 | Increased CSF lactate (HP:0002490) | 2.57856811 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.56246485 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.56202378 |
| 67 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.55082375 |
| 68 | Increased serum lactate (HP:0002151) | 2.51998686 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.51779513 |
| 70 | Unsteady gait (HP:0002317) | 2.51762646 |
| 71 | Abnormality of the lower motor neuron (HP:0002366) | 2.49137456 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.48177536 |
| 73 | Preauricular pit (HP:0004467) | 2.46108495 |
| 74 | Periauricular skin pits (HP:0100277) | 2.46108495 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.45925983 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43796126 |
| 77 | Oligomenorrhea (HP:0000876) | 2.43060778 |
| 78 | Lactic acidosis (HP:0003128) | 2.42742296 |
| 79 | Posterior subcapsular cataract (HP:0007787) | 2.39843711 |
| 80 | Increased muscle lipid content (HP:0009058) | 2.39184038 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 2.38075526 |
| 82 | Ectopic kidney (HP:0000086) | 2.37774624 |
| 83 | Microvesicular hepatic steatosis (HP:0001414) | 2.37674587 |
| 84 | Popliteal pterygium (HP:0009756) | 2.37625366 |
| 85 | Dysmetria (HP:0001310) | 2.37477345 |
| 86 | Abnormality of the labia minora (HP:0012880) | 2.36831646 |
| 87 | Type I transferrin isoform profile (HP:0003642) | 2.36147136 |
| 88 | Self-mutilation (HP:0000742) | 2.34948452 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34241522 |
| 90 | Microretrognathia (HP:0000308) | 2.33727632 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 2.32537126 |
| 92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32337184 |
| 93 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32337184 |
| 94 | Abnormal protein glycosylation (HP:0012346) | 2.32337184 |
| 95 | Abnormal glycosylation (HP:0012345) | 2.32337184 |
| 96 | Facial cleft (HP:0002006) | 2.32238590 |
| 97 | Inability to walk (HP:0002540) | 2.31774942 |
| 98 | Abnormality of the astrocytes (HP:0100707) | 2.30923466 |
| 99 | Astrocytoma (HP:0009592) | 2.30923466 |
| 100 | Scanning speech (HP:0002168) | 2.29981120 |
| 101 | Fetal akinesia sequence (HP:0001989) | 2.28290383 |
| 102 | Abnormality of binocular vision (HP:0011514) | 2.26885946 |
| 103 | Diplopia (HP:0000651) | 2.26885946 |
| 104 | Hypokinesia (HP:0002375) | 2.26590335 |
| 105 | Specific learning disability (HP:0001328) | 2.25902408 |
| 106 | Torticollis (HP:0000473) | 2.25285102 |
| 107 | Hypoventilation (HP:0002791) | 2.23946869 |
| 108 | Generalized aminoaciduria (HP:0002909) | 2.23946437 |
| 109 | Spastic gait (HP:0002064) | 2.23684379 |
| 110 | Mutism (HP:0002300) | 2.23513944 |
| 111 | Status epilepticus (HP:0002133) | 2.22827468 |
| 112 | Bradykinesia (HP:0002067) | 2.22521281 |
| 113 | Postural instability (HP:0002172) | 2.22459470 |
| 114 | Focal dystonia (HP:0004373) | 2.22137422 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 2.21756627 |
| 116 | Urinary urgency (HP:0000012) | 2.21748416 |
| 117 | Entropion (HP:0000621) | 2.21309648 |
| 118 | Septate vagina (HP:0001153) | 2.19750657 |
| 119 | Cerebral edema (HP:0002181) | 2.19622175 |
| 120 | CNS demyelination (HP:0007305) | 2.17733313 |
| 121 | Termporal pattern (HP:0011008) | 2.17400533 |
| 122 | Insidious onset (HP:0003587) | 2.17400533 |
| 123 | Methylmalonic aciduria (HP:0012120) | 2.15473194 |
| 124 | Acute encephalopathy (HP:0006846) | 2.14709064 |
| 125 | Exercise intolerance (HP:0003546) | 2.14287916 |
| 126 | Abnormal number of incisors (HP:0011064) | 2.11509713 |
| 127 | Long palpebral fissure (HP:0000637) | 2.11414834 |
| 128 | Tetraplegia (HP:0002445) | 2.10817294 |
| 129 | Genetic anticipation (HP:0003743) | 2.09091632 |
| 130 | Renal cortical cysts (HP:0000803) | 2.08802793 |
| 131 | Absent speech (HP:0001344) | 2.08420763 |
| 132 | Protruding tongue (HP:0010808) | 2.07505553 |
| 133 | Mitochondrial inheritance (HP:0001427) | 2.05938442 |
| 134 | Impaired vibratory sensation (HP:0002495) | 2.05874265 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 2.05539471 |
| 136 | Impaired pain sensation (HP:0007328) | 2.04940960 |
| 137 | Abnormality of pain sensation (HP:0010832) | 2.04940960 |
| 138 | Blue irides (HP:0000635) | 2.04700795 |
| 139 | Narrow nasal bridge (HP:0000446) | 2.04234128 |
| 140 | Esotropia (HP:0000565) | 2.02840196 |
| 141 | Craniofacial dystonia (HP:0012179) | 2.02035407 |
| 142 | Hyperthyroidism (HP:0000836) | 2.01612751 |
| 143 | Hemiparesis (HP:0001269) | 2.01437548 |
| 144 | Generalized myoclonic seizures (HP:0002123) | 2.01219763 |
| 145 | Delusions (HP:0000746) | 2.00259662 |
| 146 | Agitation (HP:0000713) | 1.99855179 |
| 147 | Resting tremor (HP:0002322) | 1.99664084 |
| 148 | Ectropion (HP:0000656) | 1.97796482 |
| 149 | Impaired smooth pursuit (HP:0007772) | 1.97679212 |
| 150 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96613856 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.96613856 |
| 152 | Sleep apnea (HP:0010535) | 1.94980570 |
| 153 | Cholecystitis (HP:0001082) | 1.94215231 |
| 154 | Abnormal gallbladder physiology (HP:0012438) | 1.94215231 |
| 155 | Dysmetric saccades (HP:0000641) | 1.94141972 |
| 156 | Trismus (HP:0000211) | 1.93004369 |
| 157 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.92488889 |
| 158 | Squamous cell carcinoma (HP:0002860) | 1.91875390 |
| 159 | Genital tract atresia (HP:0001827) | 1.91116103 |
| 160 | Lower limb muscle weakness (HP:0007340) | 1.90846779 |
| 161 | Vaginal atresia (HP:0000148) | 1.89946115 |
| 162 | Anal atresia (HP:0002023) | 1.89634909 |
| 163 | Generalized hypotonia (HP:0001290) | 1.88097216 |
| 164 | Glioma (HP:0009733) | 1.87421346 |
| 165 | Increased serum pyruvate (HP:0003542) | 1.86698542 |
| 166 | Abnormality of glycolysis (HP:0004366) | 1.86698542 |
| 167 | Redundant skin (HP:0001582) | 1.86530432 |
| 168 | Acute hepatic failure (HP:0006554) | 1.85919696 |
| 169 | Cholelithiasis (HP:0001081) | 1.85840773 |
| 170 | Rhabdomyolysis (HP:0003201) | 1.85102292 |
| 171 | Coarctation of aorta (HP:0001680) | 1.84647362 |
| 172 | Rough bone trabeculation (HP:0100670) | 1.83918680 |
| 173 | Emotional lability (HP:0000712) | 1.83686558 |
| 174 | CNS hypomyelination (HP:0003429) | 1.82326760 |
| 175 | Methylmalonic acidemia (HP:0002912) | 1.80261830 |
| 176 | Abnormality of the fingertips (HP:0001211) | 1.79083274 |
| 177 | Ependymoma (HP:0002888) | 1.78491090 |
| 178 | J-shaped sella turcica (HP:0002680) | 1.75992518 |
| 179 | Absent thumb (HP:0009777) | 1.75432794 |
| 180 | Abnormal gallbladder morphology (HP:0012437) | 1.74875414 |
| 181 | Abnormality of cochlea (HP:0000375) | 1.74243429 |
| 182 | Fibular aplasia (HP:0002990) | 1.73401494 |
| 183 | Hypoproteinemia (HP:0003075) | 1.72766759 |
| 184 | Retinal dysplasia (HP:0007973) | 1.72284995 |
| 185 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69473437 |
| 186 | Lethargy (HP:0001254) | 1.68751162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.32877028 |
| 2 | NTRK3 | 3.99167721 |
| 3 | BUB1 | 3.91265049 |
| 4 | STK24 | 3.91018617 |
| 5 | BCKDK | 3.89176943 |
| 6 | WNK4 | 3.52699798 |
| 7 | MAP3K12 | 3.44267289 |
| 8 | MAP3K4 | 3.40720037 |
| 9 | EPHA4 | 3.30031984 |
| 10 | MAP2K7 | 3.12556104 |
| 11 | TESK2 | 3.03128703 |
| 12 | MAP3K9 | 3.01778317 |
| 13 | TXK | 2.94911239 |
| 14 | STK39 | 2.92418807 |
| 15 | MARK1 | 2.81899195 |
| 16 | ZAK | 2.60707483 |
| 17 | MINK1 | 2.56585018 |
| 18 | KDR | 2.56195666 |
| 19 | MAPKAPK3 | 2.49139062 |
| 20 | EEF2K | 2.43211227 |
| 21 | DAPK2 | 2.37212867 |
| 22 | SRPK1 | 2.34440437 |
| 23 | CDK19 | 2.27456596 |
| 24 | MAP2K4 | 2.14304892 |
| 25 | PLK2 | 2.13844144 |
| 26 | DAPK1 | 1.93002781 |
| 27 | NTRK2 | 1.83072406 |
| 28 | VRK2 | 1.75350824 |
| 29 | ILK | 1.73100865 |
| 30 | TESK1 | 1.68233713 |
| 31 | MAP3K3 | 1.65235200 |
| 32 | PAK6 | 1.61439918 |
| 33 | GRK5 | 1.57986853 |
| 34 | ARAF | 1.56864542 |
| 35 | PRPF4B | 1.55346785 |
| 36 | TTK | 1.48734312 |
| 37 | AKT3 | 1.47536142 |
| 38 | CCNB1 | 1.46107296 |
| 39 | MAP3K11 | 1.44631075 |
| 40 | CHEK2 | 1.44562624 |
| 41 | MAPK13 | 1.42784661 |
| 42 | CDC7 | 1.41257585 |
| 43 | KSR1 | 1.40980864 |
| 44 | OXSR1 | 1.35026737 |
| 45 | PRKCG | 1.34596620 |
| 46 | PIM2 | 1.34095618 |
| 47 | CDK5 | 1.33522266 |
| 48 | TSSK6 | 1.28136726 |
| 49 | TRIM28 | 1.27717914 |
| 50 | KSR2 | 1.27616055 |
| 51 | MAP4K2 | 1.25247204 |
| 52 | SIK3 | 1.21005475 |
| 53 | PRKCQ | 1.19810988 |
| 54 | NTRK1 | 1.19643168 |
| 55 | EIF2AK3 | 1.17906010 |
| 56 | PRKD3 | 1.16797687 |
| 57 | PNCK | 1.14996236 |
| 58 | SGK223 | 1.11069472 |
| 59 | SGK494 | 1.11069472 |
| 60 | CAMK2A | 1.09789216 |
| 61 | CAMKK1 | 1.09771278 |
| 62 | NME1 | 1.08489130 |
| 63 | CSNK1A1L | 1.06628625 |
| 64 | UHMK1 | 1.06249263 |
| 65 | BRSK1 | 1.05175548 |
| 66 | PDK4 | 0.98555231 |
| 67 | PDK3 | 0.98555231 |
| 68 | SGK2 | 0.97616879 |
| 69 | TNIK | 0.97156841 |
| 70 | RIPK4 | 0.96519031 |
| 71 | CDK18 | 0.96204665 |
| 72 | CAMK2B | 0.91684289 |
| 73 | CDK14 | 0.91514509 |
| 74 | PHKG1 | 0.90757023 |
| 75 | PHKG2 | 0.90757023 |
| 76 | CSNK1G1 | 0.90750724 |
| 77 | JAK3 | 0.89633255 |
| 78 | CAMKK2 | 0.89232044 |
| 79 | CDK15 | 0.88713084 |
| 80 | AURKA | 0.88174205 |
| 81 | WNK3 | 0.86585734 |
| 82 | BCR | 0.85904571 |
| 83 | STK38 | 0.85650532 |
| 84 | NEK1 | 0.84739900 |
| 85 | NME2 | 0.84460492 |
| 86 | BRAF | 0.83725612 |
| 87 | NUAK1 | 0.79646291 |
| 88 | LATS2 | 0.79234319 |
| 89 | ATR | 0.77988757 |
| 90 | FES | 0.77313783 |
| 91 | PTK2B | 0.77047325 |
| 92 | PLK1 | 0.76072646 |
| 93 | SIK2 | 0.75988146 |
| 94 | CDK11A | 0.75969383 |
| 95 | MAPKAPK5 | 0.74723806 |
| 96 | PRKCE | 0.73956091 |
| 97 | BMPR2 | 0.73863287 |
| 98 | VRK1 | 0.72707825 |
| 99 | PAK3 | 0.72603365 |
| 100 | FER | 0.70475487 |
| 101 | DYRK1A | 0.67445889 |
| 102 | CSNK1G2 | 0.65110762 |
| 103 | IRAK3 | 0.64015450 |
| 104 | MAP3K2 | 0.63619116 |
| 105 | SGK3 | 0.61366730 |
| 106 | DAPK3 | 0.61315046 |
| 107 | CAMK2G | 0.60691032 |
| 108 | EPHA2 | 0.60257521 |
| 109 | CAMK1 | 0.59989219 |
| 110 | PRKCH | 0.59260466 |
| 111 | PINK1 | 0.57727192 |
| 112 | PDK2 | 0.56199228 |
| 113 | ADRBK1 | 0.55714199 |
| 114 | CAMK2D | 0.55651818 |
| 115 | GRK7 | 0.54567325 |
| 116 | TNK2 | 0.54196993 |
| 117 | MYLK | 0.53625454 |
| 118 | SGK1 | 0.52932870 |
| 119 | LMTK2 | 0.52326751 |
| 120 | PBK | 0.52067101 |
| 121 | ADRBK2 | 0.51072455 |
| 122 | STK11 | 0.50859727 |
| 123 | RPS6KA5 | 0.50013104 |
| 124 | LIMK1 | 0.49454654 |
| 125 | MAP3K13 | 0.48579538 |
| 126 | MAP2K1 | 0.48076036 |
| 127 | PRKCI | 0.47576838 |
| 128 | TYRO3 | 0.47455136 |
| 129 | ERBB3 | 0.45708241 |
| 130 | EIF2AK1 | 0.44474842 |
| 131 | STK4 | 0.43613900 |
| 132 | PRKCZ | 0.43295191 |
| 133 | MAP3K5 | 0.42455660 |
| 134 | RET | 0.42123145 |
| 135 | WEE1 | 0.41564070 |
| 136 | MAPK11 | 0.41174549 |
| 137 | RAF1 | 0.40771031 |
| 138 | PAK1 | 0.40575859 |
| 139 | ROCK2 | 0.39496453 |
| 140 | EIF2AK2 | 0.38998358 |
| 141 | AURKB | 0.38709970 |
| 142 | RPS6KA3 | 0.37864838 |
| 143 | RPS6KL1 | 0.36331217 |
| 144 | RPS6KC1 | 0.36331217 |
| 145 | MUSK | 0.35139601 |
| 146 | TLK1 | 0.35079193 |
| 147 | PRKACA | 0.34699289 |
| 148 | RPS6KA6 | 0.33249884 |
| 149 | RPS6KA2 | 0.33229215 |
| 150 | AKT2 | 0.32393339 |
| 151 | PLK3 | 0.31907636 |
| 152 | CSNK1G3 | 0.31415037 |
| 153 | MAP3K1 | 0.30786712 |
| 154 | SCYL2 | 0.30748591 |
| 155 | CAMK4 | 0.30738298 |
| 156 | CSNK2A1 | 0.26971185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.20358923 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.26213804 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 4.12502416 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.10227250 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81649351 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74654447 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.54964938 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.54468507 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.48372274 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45755665 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.39443256 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.36610012 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31094375 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26569975 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21434297 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.14254443 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08970101 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.06163665 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.04923360 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.04198422 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01162387 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96400732 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.94496857 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92219053 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.90656209 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.87688416 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.85456280 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.84318516 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.79784478 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74033727 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.70488269 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70165122 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69891529 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68993355 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66065037 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.62670958 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62484987 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60417806 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.60231001 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59713312 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59030963 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58997457 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.56264968 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.52748207 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49645936 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.47695600 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.47561740 |
| 48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47394158 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43669206 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43066064 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42200739 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.41552570 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38619606 |
| 54 | Protein export_Homo sapiens_hsa03060 | 1.37825493 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.35911424 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35224521 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34465807 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34001044 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31488611 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27341345 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26764265 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26746128 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18378397 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 1.16988426 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10818345 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10477959 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08470744 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08063748 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07956865 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 1.04925997 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04566470 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03990792 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03907230 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00987608 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97058901 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94556525 |
| 77 | Spliceosome_Homo sapiens_hsa03040 | 0.93873101 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93800456 |
| 79 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.92539645 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.89808252 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.89561308 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88134803 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88011704 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.87592661 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86965427 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82879828 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82798495 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82771120 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.81691816 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81449142 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80742442 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80525375 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79678521 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.77094998 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75905451 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74911342 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.74884177 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74180738 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74083048 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73785243 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71515865 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71337885 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69170905 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.66947805 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65463137 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64668148 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61066717 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.60509652 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60149641 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59029496 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58648406 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57911469 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57209052 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57197395 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56123963 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54954154 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54439382 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53846059 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.53547835 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52443133 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.50640772 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49855104 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49399563 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49096818 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47378781 |
| 126 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47033627 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.45377428 |
| 128 | Ribosome_Homo sapiens_hsa03010 | 0.45019571 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42708289 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42063985 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41009656 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40616737 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40142902 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38187245 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38080871 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.37964434 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37277943 |
| 138 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35286919 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34380826 |
| 140 | Bile secretion_Homo sapiens_hsa04976 | 0.34096853 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33446076 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.33294852 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32587594 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31853183 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31390384 |
| 146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31359170 |
| 147 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31265819 |
| 148 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29460691 |
| 149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29055955 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28802996 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27036803 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25893978 |
| 153 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25572172 |
| 154 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25137986 |
| 155 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25024731 |
| 156 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24917654 |
| 157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24872039 |
| 158 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24713669 |
| 159 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24580213 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22077999 |
| 161 | Carbon metabolism_Homo sapiens_hsa01200 | 0.21974004 |
| 162 | Endocytosis_Homo sapiens_hsa04144 | 0.21881005 |
| 163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21277976 |
| 164 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19598192 |
| 165 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19054719 |

